Cerezyme

Product manufactured by Genzyme Corporation

Application Nr Approved Date Route Status External Links
BLA020367 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Cerezyme ® (Imiglucerase For Injection) Is Indicated For Long-Term Enzyme Replacement Therapy For Pediatric And Adult Patients With A Confirmed Diagnosis Of Type 1 Gaucher Disease That Results In One Or More Of The Following Conditions: Anemia Thrombocytopenia Bone Disease Hepatomegaly Or Splenomegaly

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Imiglucerase

Comments